Alnylam Pharmace. buy AlexM84
Start price
17.03.24
/
50%
€134.80
Target price
17.04.24
-
Performance (%)
0.48%
End price
18.04.24
€135.45
Summary
This prediction ended on 18.04.24 with a price of €135.45. The BUY prediction by AlexM84 for Alnylam Pharmace. closed nearly unchanged. AlexM84 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 2.595% | 2.595% | -11.420% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by AlexM84 for this prediction
In the thread Trading Alnylam Pharmace.
Die von AlexM84 gewählte maximale Laufzeit wurde überschritten